These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. In vivo RNA transcript-releasing plasmid possessing a universal pseudo-terminator by means of artificial ribozymes. Ohme-Takagi M; Shinshi H; Oda M; Uchimaru T; Nishikawa S; Taira K Nucleic Acids Symp Ser; 1990; (22):49-50. PubMed ID: 1714571 [TBL] [Abstract][Full Text] [Related]
30. Construction of new hairpin ribozymes with replaced domains. Komatsu Y; Kanzaki I; Koizumi M; Ohtsuka E Nucleic Acids Symp Ser; 1995; (34):223-4. PubMed ID: 8841632 [TBL] [Abstract][Full Text] [Related]
31. Catalytic strategies of the hepatitis delta virus ribozymes. Shih IH; Been MD Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114 [TBL] [Abstract][Full Text] [Related]
32. Group I intron ribozymes. Nielsen H Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064 [TBL] [Abstract][Full Text] [Related]
33. Hammerhead ribozymes as therapeutic agents for bladder cancer. Irie A; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S Mol Urol; 2000; 4(2):61-6. PubMed ID: 12006244 [TBL] [Abstract][Full Text] [Related]
34. A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection. Welch PJ; Tritz R; Yei S; Leavitt M; Yu M; Barber J Gene Ther; 1996 Nov; 3(11):994-1001. PubMed ID: 9044745 [TBL] [Abstract][Full Text] [Related]
39. [Circumventing multidrug resistance in human cancer by anti-ribozyme]. Funato T Nihon Rinsho; 1997 May; 55(5):1116-21. PubMed ID: 9155162 [TBL] [Abstract][Full Text] [Related]
40. [Internal symmetry of the mirror type in the primary structure of ribozymes]. Shpakov AO Tsitologiia; 2002; 44(6):561-9. PubMed ID: 12236100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]